No profile data available.
Vincerx Pharma, Inc. (VINC) is a healthcare company in the blood cancer treatment drugs industry, based in San Mateo, United States, with about 12 full-time employees.
It reported revenue of $0 for fiscal year 2024, and net income of -$30.07 million. In Q1 2025 (the quarter ended March 31, 2025) revenue was $0. Its market capitalization was $62,811 as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of December 4, 2025.
Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company that develops differentiated and novel therapies to address the unmet medical needs of patients with cancer in the United States.
Vincerx Pharma reported $0 in revenue for fiscal year 2024. In Q1 2025 revenue was $0.
$62,811 as of December 4, 2025.
Listed companies of a similar size in the same industry (blood cancer treatment drugs) include Aptevo Therapeutics Inc. (APVO), Alaunos Therapeutics, Inc. (TCRT), CERo Therapeutics Holdings, Inc. (CERO), Bio-Path Holdings, Inc. (BPTH).